Asset Details
Do you wish to reserve the book?
Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk of postinterventional pancreatitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk of postinterventional pancreatitis
Do you wish to request the book?
Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk of postinterventional pancreatitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk of postinterventional pancreatitis
2013
Overview
Background
Pancreatitis is the most feared complication of endoscopic papillectomy (EP). Prevention by pancreatic duct stenting following EP has been advocated but not proven by a randomized trial. The purpose of the present retrospective review is to compare a period of systematic stenting with the period before in which stents were placed selectively.
Methods
A total of 107 patients undergoing EP from February 1999 to December 2009 were retrospectively reviewed. After an initial period with selective stenting (dilated duct, previous pancreatitis) between 1999 and 2002 (
n
= 24, group 1), stents were placed routinely after EP unless pancreas divisum was diagnosed (2002–2009;
n
= 83, group 2) to reduce postpapillectomy acute pancreatitis (PAP). PAP rates defined by Consensus Criteria were compared in the two periods.
Results
Five patients in group 1 were selected to receive a pancreatic stent (21 %); in group 2 stenting was successful in 75 of 78 patients (success rate 96 %) without pancreas divisum (
n
= 5). Overall, PAP occurred in 11 % of patients. PAP rate was significantly reduced after introduction of systematic pancreatic stenting (5 vs 25 %;
p
= 0.01) and occurred less often in stented than in nonstented patients: (5 % (4/80) vs 27 % (6/22),
p
= 0.0019). PAP also occurred in one of five patients with pancreas divisum. Selective stenting of patients also was an independent risk factor for PAP (OR 13,
p
= 0.001) in a multivariate analysis.
Conclusions
Attempts at systematic stenting after EP pancreatic stenting appears to prevent PAP. Results should be corroborated by a randomized trial.
Publisher
Springer US,Springer Nature B.V
